Goal Statement

The primary goal of this educational activity is to encourage the application of the latest advances in evidence-based medicine to improve the quality of care and improve outcomes for the patients affected by anemia and GI disease.

Target Audience

This activity is designed for gastroenterologists, nurse practitioners (NPs), physician assistants (PAs) and nurses.

Educational Objectives

Upon completion of this activity, participants should be better able to:

Describe the prevalence of IDA in patients with IBD

Identify patients with IDA

Describe the pathophysiologic processes that underlie IDA in patients with IBD

Differentiate among various oral and IV iron formulations and incorporate them effectively into clinical practice

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the Annenberg Center for Health Sciences at Eisenhower and the GI Health Foundation. The Annenberg Center for Health Sciences at Eisenhower is accredited by the ACCME to provide continuing medical education for physicians.

The Annenberg Center for Health Sciences at Eisenhower designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc., all other staff at the Annenberg Center for Health Sciences at Eisenhower and the GI Health Foundation have no relationships to disclose.

Learner Assurance Statement

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

This activity is supported by an educational grant from AMAG Pharmaceutical, Inc.

Provided by

Accredited by

Americans with Disabilities Act

The event staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact us prior to the event at 877-782-4532.

Target Audience

Gastroenterologists, internists, family practitioners, physician assistants, physicians-in-training and researchers with an interest in the pathophysiology, diagnosis, and clinical management of gastrointestinal and other common diseases and their relationship to the microbiome.

Educational Objectives

After completing this activity, participants should be better able to:

Discuss evolving concepts regarding the role of the gut microbiome in gastrointestinal and liver health.

Describe current research advances in understanding the composition and function of the gut microbiome.

Discuss how modification of the gut microbiome can be used as a therapeutic strategy in gastrointestinal and liver health.

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Cincinnati and the Gastrointestinal Health Foundation (GIHF). The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.

The University of Cincinnati designates this live activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement

All faculty and staff involved in the planning or presentation of continuing education activities provided by the University of Cincinnati are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity.

All additional planning committee members, Gastrointestinal Health Foundation staff, and the University of Cincinnati staff have no relationships to disclose.

Learner Assurance Statement

The University of Cincinnati is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The University of Cincinnati is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Off-Label Disclosure Statement

Faculty members are required to inform the audience when they are discussing off-label, unapproved uses of devices and drugs. Physicians should consult full prescribing information before using any product mentioned during this educational activity.

Americans with Disabilities Act

The event staff will be glad to assist you with any special needs (i.e., physical, dietary). Please contact us prior to the event at 1-973-520-1810.

Provided by

Accredited by